Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FALP-COVID Convalescent Plasma Trial
NCT04384588Phase 3Unknown
- Sponsor
- Fundación Arturo López Pérez
- Start
- Apr 2020
- Primary completion
- Apr 2021
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Fundación Arturo López Pérez. Primary endpoints: In-hospital mortality secondary to COVID-19 at 1 year and Safety of the use of convalescent plasma at 1 year. Status: unknown.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04384588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04384588.